摘要
Objective(s): Cisplatin (CDDP) is a highly effective chemotherapeutic agent, but its clinical application has been limited by nephrotoxicity. Tanshinone I (T-I), a phenanthrenequinone compound extracted from the Chinese herb Danshen, has been used to improve circulation and treat cardiovascular diseases. The aim of this study was to investigate the protective effect of T-I on CDDP-induced nephrotoxicity in mice. @@@ Materials and Methods: The BALB/c mouse models of nephrotoxicity were established by a single intraperitoneal injection of 20 mg/kg CDDP on the first day of the experiment. Three hours prior to CDDP administration, the mice were dosed with 10 mg/kg and 30 mg/kg T-I for 3 consecutive days intraperitoneally to explore nephroprotection of T-I. @@@ Results: Treatment with T-I significantly reduced blood urea nitrogen and creatinine levels in serum observed in CDDP-administered mice, especially at a dose of 30 mg/kg. T-I at 30 mg/kg significantly decreased malondialdehyde levels and increased glutathione levels and the enzymatic activity of catalase in kidney tissue compared to CDDP. Additionally, T-I (30 mg/kg) significantly reversed the CDDP-decreased expression level of superoxide dismutase 2 protein in renal tissue. Histopathological evaluation of the kidneys further confirmed the protective effect of T-I. @@@ Conclusion: The findings of this study demonstrate that T-I can protect against CDDP-induced nephrotoxicity through suppression of oxidative stress.
学科与关键词
- Raloxifene Protects Cisplatin-Induced Renal Injury in Mice via Inhibiting Oxidative StressAn, Jian-Hong; Li, Chun-Yan; Chen, Chun-Ya; Wu, Jian-Bin; Shen, Hong*OncoTargets and Therapy, 2021, 14: 4879-4890.被引 2
- Protective effect of Shenfushu granules on nephrotoxicity induced by cisplatin in miceCAO Si si; GONG Shuang; YAN Miao; JIANG Yun sheng; FAN Xin rong; ZHANG Bi kui中国临床药理学杂志, 2017, 33(6).
- Salvia miltiorrhiza Bunge (Danshen) and Bioactive Compound Tanshinone IIA Alleviates Cisplatin-Induced Acute Kidney Injury Through Regulating PXR/NF-κB SignalingDou, Jing-Yun; Zhang, Min; Cen, Huan; Chen, Yi-Qin; Wu, Yi-Fan; Lu, Fuhua; Zhou, Jiuyao; Liu, Xu-Sheng*; Gu, Yue-Yu*Frontiers in Pharmacology, 2022, 13: 860383.被引 9
